| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...854723C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0054723 |
| P932 | PMC publication ID | 3554640 |
| P698 | PubMed publication ID | 23359807 |
| P5875 | ResearchGate publication ID | 235381224 |
| P50 | author | Alessandra Balduini | Q56972276 |
| P2093 | author name string | Carlo L Balduini | |
| Manuela Currao | |||
| P2860 | cites work | Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. | Q53457979 |
| Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets | Q61942736 | ||
| Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin | Q24316187 | ||
| Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes | Q28142403 | ||
| A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation | Q28475435 | ||
| AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. | Q33373031 | ||
| Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial | Q33378523 | ||
| Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. | Q33381893 | ||
| Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C. | Q33385482 | ||
| Biology and chemistry of thrombopoietic agents | Q33390625 | ||
| A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia | Q33394959 | ||
| Megakaryocytes and beyond: the birth of platelets | Q34215516 | ||
| Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes | Q34280678 | ||
| Roads to polyploidy: the megakaryocyte example | Q34504475 | ||
| The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production | Q34658539 | ||
| Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes | Q36313419 | ||
| The mitogen-activated protein kinase signaling pathways: role in megakaryocyte differentiation | Q37623945 | ||
| PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1). | Q40015626 | ||
| Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation | Q42574292 | ||
| AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. | Q44704490 | ||
| Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. | Q46501234 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | romiplostim | Q1235195 |
| P304 | page(s) | e54723 | |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytes | |
| P478 | volume | 8 |
| Q41480921 | A new path to platelet production through matrix sensing. |
| Q50091910 | A novel mode of stimulating platelet formation activity in megakaryocytes with peanut skin extract |
| Q36596892 | CCL5 derived from platelets increases megakaryocyte proplatelet formation |
| Q33442148 | Developmental differences between newborn and adult mice in response to romiplostim |
| Q47720114 | Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura |
| Q33417148 | Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia |
| Q42335815 | Eltrombopag, a potent stimulator of megakaryopoiesis. |
| Q38187494 | Ex vivo production of platelets from stem cells |
| Q41510461 | Hyaluronan based hydrogels provide an improved model to study megakaryocyte-matrix interactions |
| Q33420441 | Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro |
| Q90733820 | Induction of differentiation of human stem cells ex vivo: Toward large-scale platelet production |
| Q26745753 | Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia |
| Q33434519 | Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation |
| Q44643430 | Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization |
| Q33440990 | Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy |
| Q28082685 | The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control |
| Q48320457 | Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres. |
Search more.